Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

roche__tree

Roche’s Tecentriq combo outclasses Nexavar in unresectable hepatocellular carcinoma

November 25, 2019 Research and Development, Sales and Marketing Cancer, Roche, immunotherapy, pharma, tecentriq

Roche has revealed new Phase 3 data for its immunotherapy drug Tecentriq (atezolizumab) in combination with Avastin (bevacizumab) in the …
News
uk

Scotland leading the UK in life science start-up growth, report reveals

November 20, 2019 Research and Development, Sales and Marketing BioCity, UK, biotech, pharma

A new report published by the life science incubator and business collective BioCity has painted a promising picture of UK …
News
lilly_building_with_american_flag_web

Lilly to boost Indianapolis manufacturing site with $400m injection, 100 jobs to be created

November 20, 2019 Manufacturing and Production, Research and Development Eli Lilly, US, pharma

Eli Lilly is poised to boost its manufacturing capacity with the investment of $400 million at its Lilly Technology Center …
News
merck-keytruda

Europe approves Keytruda for first-line head and neck squamous cell carcinoma, as a monotherapy or combo

November 20, 2019 Research and Development, Sales and Marketing Cancer, keytruda, pharma

MSD’s top-selling immunotherapy Keytruda (pembrolizumab) has secured another approval from the European Commission, this time in the first-line treatment of …
News
allergan

Allergan’s acute migraine therapy ubrogepant shows strength at Phase 3

November 20, 2019 Research and Development Allergan, pharma, ubrogepant

Allergan has revealed positive Phase 3 data on its oral calcitonin gene-related peptide (CGRP) receptor antagonist ubrogepant, illustrating the therapy’s …
News
darzalex-product-shot---100mg-vial-2-hr

European Commission approves Genmab’s Darzalex combo in newly diagnosed multiple myeloma

November 20, 2019 Research and Development, Sales and Marketing Europe, Genmab, darzalex, pharma

Genmab’s Darzalex (daratumumab) has secured approval from the European Commission and is now authorised in Europe for the treatment of …
News
shutterstock

Bayer and MSD’s chronic heart failure drug meets main goal at Phase 3

November 19, 2019 Manufacturing and Production, Research and Development Bayer, MSD, pharma, vericiguat

MSD and Bayer have made it known that their jointly-developed soluble guanylate cyclase (sGC) stimulator vericiguat met its primary endpoint …
News
vertex-headquarters

Data revealed on novel CRISPR/Cas9 gene-editing therapy for first two severe haemoglobinopathy patients

November 19, 2019 Manufacturing and Production, Research and Development Vertex, crispr, pharma

Vertex and CRISPR Therapeutics have unveiled the first interim Phase 1/2 data demonstrating the safety and efficacy of the investigational …
News
capture

Bringing the clinical trial home

November 18, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing clinical trials, feature, research

Clinical trials are the backbone of healthcare and drug research, but many key patient populations have in the past been …
Feature
shutter

resTORbio shuts down Phase 3 trial in clinically symptomatic respiratory illness

November 18, 2019 Research and Development, Sales and Marketing pharma, resTORbio

US firm resTORbio has revealed its intention to terminate a Phase 3 trial of its oral, selective TORC1 inhibitor RTB101 …
News
jazz_pharma

Jazz Pharma sleep disorder drug secures CHMP backing for treatment of excessive daytime sleepiness in Europe

November 18, 2019 Research and Development, Sales and Marketing EMA, jazz pharma, narcolepsy, pharma, solriamfetol

Jazz Pharma’s solriamfetol has secured a positive opinion from the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human …
News
Facebook image

Over half of all anti-vaccine ads on Facebook stem from just two advertisers

November 15, 2019 Medical Communications, Research and Development Facebook, anti-vaccine, pharma

A new study has revealed that the largest share of anti-vaccine advertisements on Facebook originate from just two organisations, both …
News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

November 15, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

As we close in on the weekend, it’s been a week characterised by data reveals and crucial marketing approvals, including …
News
diabetes-777001_960_720

New report reveals shocking knowledge gaps around type 2 diabetes risk factors

November 14, 2019 Medical Communications, Research and Development Merck KGaA, diabetes, pharma, type 2 diabetes

A new report released on World Diabetes Day has shone a light on a startling lack of knowledge surrounding type …
News
sarah_mcdonald

Myeloma UK reveals new Director of Research appointment

November 14, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Myleoma UK, appointment, multiple myeloma, pharma

UK non-profit organisation Myeloma UK has selected Sarah McDonald as its new Director of Research, who in her new role …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025